03/03/2022
The IMI project IMPENTRI’s trial of a cancer drug has shown promising results after 90 days, confirming its benefits in severe cases.
Site Search
Site Search
Displaying results 231 - 240 of 519
28/02/2022
IMI rare disease research focusses on gene therapy delivery systems, newborn screening, platform trials for neurofibromatosis and finding a cure for Fibrodysplasia ossificans...
25/02/2022
IMI-funded IMSAVAR reviewed the state of ‘cancer-on-chip’ technology. While promising, problems with manufacturing to scale make them impractical for the moment.
22/02/2022
The IMI-funded ITCCP4 project joined forces with US experts in paediatric cancer to reach a much-needed consensus on the best way forward for testing of childhood cancer drugs.
17/02/2022
A roundup of some recent IMI cancer progress stories, and cancer-related projects launched in 2021
15/02/2022
The IMI-funded ITCC-P4 project’s methodology helped identify some of the best targets in childhood tumours that could be candidates for treatment with adult therapies
09/02/2022
The last Innovative Medicines Initiative (IMI) project to launch, FACILITATE will explore how we can return data from clinical trials to participants.
07/02/2022
Researchers from COMBACTE-CDI filled important knowledge gaps on the scale of C. diff infections, and sequenced the genomes of hundreds of strains for future researchers
07/02/2022
Find out about our calls for tender, including upcoming opportunities and previously awarded contracts.